XOMA Royalty (XOMA) Cash from Financing Activities (2010 - 2026)

XOMA Royalty's (XOMA) quarterly Cash from Financing Activities came in at -$7.6 million in Q1 2026, down 10.82% year-on-year from -$8.6 million in Q1 2025, and up 28.52% quarter-over-quarter from -$10.7 million in Q4 2025.

XOMA Royalty (XOMA) Cash from Financing Activities (2010 - 2026) Analysis & Trends

XOMA Royalty has disclosed Cash from Financing Activities across 17 years of filings, most recently posting -$7.6 million for Q1 2026.

  • Cash from Financing Activities for Q1 2026 came in at -$7.6 million, down 10.82% year-over-year; the trailing twelve-month figure through Mar 2026 was -$27.2 million (down 108.26% YoY), and the FY2025 annual result was -$26.5 million, down 137.83% from the prior year.
  • Cash from Financing Activities came in at -$7.6 million for Q1 2026 at XOMA Royalty, up from -$10.7 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $124.5 million in Q4 2023 to a low of -$10.7 million in Q4 2025.
  • The 5-year median for Cash from Financing Activities is -$1.4 million (2023), against an average of $4.2 million.
  • Across the five-year window, Cash from Financing Activities jumped 9517.1% in 2023 and plunged 902.72% in 2025, its largest moves.
  • XOMA Royalty's Cash from Financing Activities stood at -$1.3 million in 2022, then surged by 9517.1% to $124.5 million in 2023, then sank by 100.86% to -$1.1 million in 2024, then slumped by 902.72% to -$10.7 million in 2025, then increased by 28.52% to -$7.6 million in 2026.
  • The last three Cash from Financing Activities figures came in at -$7.6 million (Q1 2026), -$10.7 million (Q4 2025), and -$5.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 7.00 Mn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -600,000.00
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 53,000.00
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn -538.80 Mn
9 Abivax 95.45 Bn 95.45 Bn - 85,464.43
10 XOMA Royalty 5.52 Mn -60.56 Mn - -7.64 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -7.64 Mn
Mar 31, 2026 -7.64 Mn
Dec 31, 2025 -10.69 Mn
Dec 31, 2025 -10.69 Mn
Sep 30, 2025 -5.85 Mn
Sep 30, 2025 -5.85 Mn
Jun 30, 2025 -3.03 Mn
Jun 30, 2025 -3.03 Mn
Mar 31, 2025 -6.89 Mn
Mar 31, 2025 -6.89 Mn
Dec 31, 2024 -1.07 Mn
Dec 31, 2024 -1.07 Mn
Sep 30, 2024 -4.00 Mn
Sep 30, 2024 -4.00 Mn
Jun 30, 2024 -1.10 Mn
Jun 30, 2024 -1.10 Mn
Mar 31, 2024 -4.96 Mn
Mar 31, 2024 -4.96 Mn
Dec 31, 2023 124.49 Mn
Dec 31, 2023 124.49 Mn